These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37296973)

  • 1. The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer.
    Zeng H; Tohidinezhad F; De Ruysscher DKM; Willems YCP; Degens JHRJ; van Kampen-van den Boogaart VEM; Pitz C; Cortiula F; Brandts L; Hendriks LEL; Traverso A
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.
    Keek SA; Kayan E; Chatterjee A; Belderbos JSA; Bootsma G; van den Borne B; Dingemans AC; Gietema HA; Groen HJM; Herder J; Pitz C; Praag J; De Ruysscher D; Schoenmaekers J; Smit HJM; Stigt J; Westenend M; Zeng H; Woodruff HC; Lambin P; Hendriks L
    Ther Adv Med Oncol; 2022; 14():17588359221116605. PubMed ID: 36032350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of radiomics signature captured from pretreatment thoracic CT to predict brain metastases in stage III/IV ALK-positive non-small cell lung cancer patients.
    Xu X; Huang L; Chen J; Wen J; Liu D; Cao J; Wang J; Fan M
    J Thorac Dis; 2019 Nov; 11(11):4516-4528. PubMed ID: 31903240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of radiomics model based on the concept of gross tumor volume and clinical target volume in predicting occult lymph node metastasis in non-small cell lung cancer.
    Zeng C; Zhang W; Liu M; Liu J; Zheng Q; Li J; Wang Z; Sun G
    Front Oncol; 2023; 13():1096364. PubMed ID: 37293586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images.
    Zhang J; Jin J; Ai Y; Zhu K; Xiao C; Xie C; Jin X
    Eur Radiol; 2021 Feb; 31(2):1022-1028. PubMed ID: 32822055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
    Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
    Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deep learning-based radiomics approach to predict head and neck tumor regression for adaptive radiotherapy.
    Tanaka S; Kadoya N; Sugai Y; Umeda M; Ishizawa M; Katsuta Y; Ito K; Takeda K; Jingu K
    Sci Rep; 2022 May; 12(1):8899. PubMed ID: 35624113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With
    Wang H; Chen YZ; Li WH; Han Y; Li Q; Ye Z
    Front Genet; 2022; 13():772090. PubMed ID: 35281837
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiomics Feature Activation Maps as a New Tool for Signature Interpretability.
    Vuong D; Tanadini-Lang S; Wu Z; Marks R; Unkelbach J; Hillinger S; Eboulet EI; Thierstein S; Peters S; Pless M; Guckenberger M; Bogowicz M
    Front Oncol; 2020; 10():578895. PubMed ID: 33364192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
    Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
    Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features.
    Wen Q; Yang Z; Dai H; Feng A; Li Q
    Front Oncol; 2021; 11():620246. PubMed ID: 34422625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
    Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A "Seed-and-Soil" Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation.
    Chu X; Gong J; Yang X; Ni J; Gu Y; Zhu Z
    Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study.
    Chen QL; Li MM; Xue T; Peng H; Shi J; Li YY; Duan SF; Feng F
    Clin Radiol; 2023 May; 78(5):e359-e367. PubMed ID: 36858926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer].
    Zhu J; Xu WG; Xiao H; Zhou Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):373-378. PubMed ID: 31631606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases.
    Cheung BMF; Lau KS; Lee VHF; Leung TW; Kong FS; Luk MY; Yuen KK
    Radiat Oncol J; 2021 Dec; 39(4):254-264. PubMed ID: 34986546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
    Sun F; Chen Y; Chen X; Sun X; Xing L
    Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.